Adam Sohn is currently Vice President, US Regional Client Leader for Global Consulting at QuintilesIMS. During his 20+ year health care career, Adam has specialized in global commercial strategy development with particular attention to pricing and market access, launch strategy, and value driven models. Adam joined the Pricing and Market Access practice in 2004 and led the Center of Excellence for P&MA in the Americas from 2010-2015. During his tenure at QuintilesIMS, Adam has supported both large and small biopharmaceutical companies with the commercialization of niche and blockbuster drugs. His experience supporting corporations with portfolio and brand strategies extends five continents and has covered a myriad of therapeutic areas across primary and specialty care, oncology, vaccines and rare diseases.
Prior to joining QuintilesIMS (previously IMS Consulting Group), Adam was an Associate equity analyst at CIBC World Markets covering the large and specialty pharmaceutical sectors and a healthcare management consultant at Ernst & Young Consulting, now Cap Gemini.
Adam holds an MBA from Columbia Business School and an undergraduate degree in Political Economy from Princeton University.